Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis


Surveillance, careful vaccine selection tops “shoot-in-the-dark” strategy for IB control


Full interview

A producer’s ability to match vaccine coverage to the circulating infectious-bronchitis threat depends largely on a well-executed surveillance program, according to Mark Jackwood, PhD, University of Georgia.

He said producers often take a “shoot-in-the-dark” approach with IB. “They starting adding IB strains into their vaccination program hoping for cross-protection without really knowing which strains are in their flocks,” Jackwood told Poultry Health Today.

Research has shown that IB vaccines don’t directly interfere with one another, but when four or more strains are used in combination, the available antigen mass can be diluted to the point where birds don’t have a robust immune response.

Vaccines with multiple strains produced by pharmaceutical companies are pre-tested for antigen response, Jackwood said. Still, employing a vaccine program with more than three strains for extended cross protection could be asking for trouble.

“The real problem begins when producers start adding a third or even fourth IB strain from another manufacturer. These additions dilute all the antigens to the point where birds can’t develop a strong immune response to any of the strains,” he explained.

According to Jackwood, surveillance programs need to look at the last year’s IB strains and begin early monitoring in the August through October time frame to assess new disease pressure.

“The only way to know what is really going on in the barn is to take nasal swabs and get them tested in the laboratory for serotypes,” he said. Today’s IB testing is rapid, real-time PCR testing allowing the lab to run a large number of samples in a timely, cost effective manner.

Sentinel birds are another useful option when birds remain sick despite IB vaccination.

“We vaccinate sentinel birds with known circulating viruses, let them develop immunity and then place them in the flock. When we remove them at the optimum time frame of 10 and 20 days for virus infection, we’re identify the pathogenic virus that’s been hiding under the surface,” he explained.

Producers are urged to actively test for circulating strains and not just use a vaccine based on history. IB pressure is different every year and a good surveillance program helps correctly identify the circulating strains.

Properly vaccinating birds ensures a good antigen response. “Make sure your vaccination machines are in good working order, that the vaccine and diluent are kept cold and each bird gets an adequate dose of the vaccine. Most importantly, don’t cut the dose,” Jackwood said.

For producers in antibiotic-free programs, secondary infections from Escherichia coli pose a greater threat. As a virus, IB remains a treatable pathogen but any damage from IB can open the door for damaging E. coli bacterial infection.

“We see the primary challenge from IB but without the antibiotic tools to fight the secondary E. coli infection, the birds will be much sicker with increased losses due to airsacculitis and higher numbers of condemnations at the processing plant,” Jackwood explained.


tags: , , , , , , ,
  • Industry trendwatcher offers insights on future of antibiotic-free poultry production

    Industry trendwatcher and analyst Greg Rennier, PhD, recently sat down with Poultry Health Today to share his thoughts on antibiotic-free production and where the poultry industry is heading in 2017 and beyond.

  • Can improper vaccination make IBV worse?

    Improper vaccination not only fails to protect flocks from infectious bronchitis virus (IBV), but it can also make the problem worse, a leading poultry health expert says. Speaking at the 2017 World Veterinary Poultry Association meeting, the University of Georgia’s...

  • Why infectious bronchitis is so resilient — and what broiler companies can do about it

    Control of infectious bronchitis (IB) requires good biosecurity, good management and rigorous administration of a vaccine that matches the circulating virus as closely as possible, John Smith, DVM, MAM, Alectryon LLC, formerly with Fieldale Farms, told Poultry Health...

  • Antibiotic-free poultry production: Is it sustainable on a large scale?

    Phil Stayer, DVM, head veterinarian at Sanderson Farms, is worried about what he calls an "anti-technology movement" directed at the US poultry industry, particularly as it relates to veterinary care and the use of FDA-approved medications. In this interview with...

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.